10,653 reports of this reaction
2.0% of all METFORMIN ER 500 MG reports
#11 most reported adverse reaction
WEIGHT DECREASED is the #11 most commonly reported adverse reaction for METFORMIN ER 500 MG, manufactured by Granules Pharmaceuticals Inc.. There are 10,653 FDA adverse event reports linking METFORMIN ER 500 MG to WEIGHT DECREASED. This represents approximately 2.0% of all 532,492 adverse event reports for this drug.
Patients taking METFORMIN ER 500 MG who experience weight decreased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WEIGHT DECREASED is a less commonly reported adverse event for METFORMIN ER 500 MG, but still significant enough to appear in the safety profile.
In addition to weight decreased, the following adverse reactions have been reported for METFORMIN ER 500 MG:
The following drugs have also been linked to weight decreased in FDA adverse event reports:
WEIGHT DECREASED has been reported as an adverse event in 10,653 FDA reports for METFORMIN ER 500 MG. This does not prove causation, but indicates an association observed in post-market surveillance data.
WEIGHT DECREASED accounts for approximately 2.0% of all adverse event reports for METFORMIN ER 500 MG, making it a notable side effect.
If you experience weight decreased while taking METFORMIN ER 500 MG, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.